Washingtoner - Global Platelet Concentration Systems Market to surpass US$ 1,110.4 million by end of 2027, Says Coherent Market Insights (CMI)

Trending...

Regional Magazines Shine at IRMA Awards
Guberman to Business Owners, Implant Patients: Your ISO 9001,ISO 13485 AS9100,AI9100 Certificate Is Dead, and Nobody Knows What's Inside You
Tickeron Launches New AI Trading Robots for Semi & Finance with Profit Factor 2.8 for Hedge Funds (JPM, BAC, NVDA, GOOG, AVGO, META, AMD)

SEATTLE--(BUSINESS WIRE)--According to Coherent Market Insights, the global platelet concentration systems market is estimated to be valued at US$ 286.99 million in 2020 and is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027).

Key Trends and Analysis:

The global platelet concentration systems market is expected to witness significant growth, owing to increasing launches of Platelet Rich Plasma systems. For instance, in 2014, Mitek Sports Medicine, a leader in orthopedics sports medicine and a part of the DePuy Synthes Companies of Johnson & Johnson, announced launch of PEAK Platelet Rich Plasma (PRP) System, a new device that produces high quality PRP in two and a half minutes.

Launches of PRP products and services is also expected to drive growth of the global platelet concentration systems market. For instance, in October 2013, The Global Stem Cells Group, Inc. announced the launch of Plasma Plus medical services in the Dominican Republic)

Furthermore, increasing geriatric population across the globe has increased the cases of orthopedic conditions and other medical problems that require plasma therapy, which is expected to drive the market growth. According to the United Nations (UN) 2019 report, there were around 703 million people globally aged 65 years and above in 2019, which is expected to reach 1.5 billion by 2050.

Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4324

Key Market Takeaways:

The global platelet concentration systems market is expected to exhibit a CAGR of 21.2% during the forecast period (2020-2027), as key players are focusing on facility expansion in order to expand their product portfolio. For instance, in October 2017, Arthrex Inc. built a new state-of-the-art surgical device and implant manufacturing facility in Anderson County, South Carolina. This investment is part of Arthrex's global expansion plan to support the development of new and innovative products that help surgeons treat their patients better.

More on Washingtoner

Competitive Landscape:

Key players operating in the global platelet concentration systems market include Anthrax Inc., Stryker Corporation, Johnson & Johnson's, Zimmer Biomet Holdings Inc., Terumo Corporation, Arteriocyte Medical Systems, Inc., Exactech Inc., Harvest Technologies Corp., and Nuo Therapeutics, Inc.

Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4324

Market Segmentation:

Global Platelet Concentration Systems Market, By Technology:
- Apheresis Technology
- Single Spin Technology
- Double Spin Technology
Global Platelet Concentration Systems Market, By End User:
- Hospital
- Orthopedic Clinics
- Sports Injury Centers
- Ambulatory Surgical Centers
Global Platelet Concentration Systems Market, By Region:
- North America
  - By Country:
    - U.S.
    - Canada
- Europe
  - By Country:
    - U.K.
    - Germany
    - France
    - Spain
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country:
    - China
    - India
    - Japan
    - Australia
    - ASEAN
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - By Country:
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Middle East
  - By Country:
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Country/Region:
    - South Africa
    - Central Africa
    - North Africa

Related Market Intelligence Reports:

More on Washingtoner

Plasma Therapy Market, By Type (Pure PRP, Leucocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), and Leukocyte-rich Fibrin (L-PRF)), By Application (Infections Diseases, Dental, Nerve Injury, Cardiac Muscle Injury, and Other Applications), By End-User (Hospitals & Clinics, Research Institutes, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/plasma-therapy-market-4155

Europe Platelet rich Plasma Market, By Product Type (Instruments, Kits (Kit By Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Leukocyte-Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)),Kit By Origin (Autologous Platelet-Rich Plasma, Homologus Platelet-Rich Plasma, Allogeneic Platelet-Rich Plasma))), By Application (Knee, Elbow, Foot and Ankle, Shoulder, CMF, Others) - Size, Share, Outlook, and Opportunity Analysis, 2019 – 2027

Read more: https://www.coherentmarketinsights.com/market-insight/europe-platelet-rich-plasma-market-3346

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.

0 Comments

Latest on Washingtoner

_catLbl0 _catLbl1